The purpose of the Reach Grant is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic.
Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Grant seeks to remove one of these barriers by providing support for important preclinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Thus, the goal of this award is to support selected late-translational studies. Preference will be given to those research projects which, if funded, will likely result in the initiation of a clinical trial in two to three years from the start of the project by, for example, completing IND-enabling studies, providing requisite preclinical data for clinical trial development, or perhaps through the validation of biomarkers that will enable selection of the correct patients for entry into new clinical trials.
Budget
The award is up to $125,000 annually for two years.
Due Date
March 22, 2021 6:00pm MST